Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
Total Valuation
Guardant Health has a market cap or net worth of $12.21B. The enterprise value is $8.54B.
Market Cap$12.21B
Enterprise Value$8.54B
Share Statistics
Guardant Health has 129,374,420 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding129,374,420
Owned by Insiders3.53%
Owned by Institutions17.97%
Financial Efficiency
Guardant Health’s return on equity (ROE) is 3.12 and return on invested capital (ROIC) is -33.74%.
Return on Equity (ROE)3.12
Return on Assets (ROA)-0.29
Return on Invested Capital (ROIC)-33.74%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee369.69K
Profits Per Employee-218.30K
Employee Count1,999
Asset Turnover0.50
Inventory Turnover4.08
Valuation Ratios
The current PE Ratio of Guardant Health is ―. Guardant Health’s PEG ratio is 0.51.
PE Ratio―
PS Ratio5.07
PB Ratio-26.85
Price to Fair Value-26.85
Price to FCF-13.64
Price to Operating Cash Flow-55.39
PEG Ratio0.51
Income Statement
In the last 12 months, Guardant Health had revenue of 739.02M and earned -436.37M in profits. Earnings per share was -3.56.
Revenue739.02M
Gross Profit449.22M
Operating Income-443.59M
Pretax Income-435.09M
Net Income-436.37M
EBITDA-390.12M
Earnings Per Share (EPS)-3.56
Cash Flow
In the last 12 months, operating cash flow was -222.90M and capital expenditures -39.33M, giving a free cash flow of -262.23M billion.
Operating Cash Flow-222.90M
Free Cash Flow-262.23M
Free Cash Flow per Share-2.03
Dividends & Yields
Guardant Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.52
52-Week Price Change225.86%
50-Day Moving Average70.75
200-Day Moving Average53.01
Relative Strength Index (RSI)69.24
Average Volume (3m)2.89M
Important Dates
Guardant Health upcoming earnings date is Feb 19, 2026, After Close (Confirmed).
Last Earnings DateOct 29, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend Date―
Financial Position
Guardant Health as a current ratio of 4.68, with Debt / Equity ratio of -366.74%
Current Ratio4.68
Quick Ratio4.36
Debt to Market Cap0.31
Net Debt to EBITDA-2.08
Interest Coverage Ratio-171.87
Taxes
In the past 12 months, Guardant Health has paid 1.28M in taxes.
Income Tax1.28M
Effective Tax Rate>-0.01
Enterprise Valuation
Guardant Health EV to EBITDA ratio is -11.69, with an EV/FCF ratio of -16.59.
EV to Sales6.17
EV to EBITDA-11.69
EV to Free Cash Flow-16.59
EV to Operating Cash Flow-19.01
Balance Sheet
Guardant Health has $580.01M in cash and marketable securities with $1.33B in debt, giving a net cash position of -$746.36M billion.
Cash & Marketable Securities$580.01M
Total Debt$1.33B
Net Cash-$746.36M
Net Cash Per Share-$5.77
Tangible Book Value Per Share-$1.22
Margins
Gross margin is 63.76%, with operating margin of -60.02%, and net profit margin of -59.05%.
Gross Margin63.76%
Operating Margin-60.02%
Pretax Margin-58.87%
Net Profit Margin-59.05%
EBITDA Margin-52.79%
EBIT Margin-58.52%
Analyst Forecast
The average price target for Guardant Health is $88.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$88.00
Price Target Upside-6.75% Downside
Analyst ConsensusStrong Buy
Analyst Count21
Revenue Growth Forecast30.38%
EPS Growth Forecast24.17%